Web Analysis for Cslbehring - cslbehring.co.uk
CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide.
cslbehring.co.uk is 1 decade 7 years old. It is a domain having co.uk extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, cslbehring.co.uk is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
Traffic Report
Daily Unique Visitors: | Not Applicable |
Daily Pageviews: | Not Applicable |
Estimated Valuation
Income Per Day: | $ 0.15 |
Estimated Worth: | $ 8.95 |
Search Engine Indexes
Google Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Safety Information
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Not Applicable |
WOT Child Safety: | Not Applicable |
Website Ranks & Scores
Alexa Rank: | Not Applicable |
Domain Authority: | Not Applicable |
Web Server Information
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
H1 Headings: | 2 | H2 Headings: | 7 |
H3 Headings: | 3 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | 1 | Total Images: | 12 |
Google Adsense: | Not Applicable | Google Analytics: | UA-39645466-47 |
Websites Hosted on Same IP (i.e. 12.3.33.229)
Plasma Donation Centers - CSL Plasma
Receive rewards without a part time job by visiting our plasma donation centers. Get rewarded to donate plasma today.
Global Rare Disease Biotech Company | CSL Behring
CSL Behring is a leading global biotech company driven by its promise to save and improve lives. We manufacture remedies for serious and rare diseases.
CSL Limited is a global biotherapy industry leader.
CSL Limited is a global biotechnology manufacturer that researches, develops, and markets products to treat and prevent rare and serious diseases. Learn more.
CSL Limited is a global biotherapy industry leader.
CSL Limited is a global biotechnology manufacturer that researches, develops, and markets products to treat and prevent rare and serious diseases. Learn more.
Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
HTTP Header Analysis
Cache-Control: no-cache, no-store
Pragma: no-cache
Content-Type: text/html; charset=utf-8
Content-Encoding: gzip
Expires: -1
Vary: Accept-Encoding
X-Frame-Options: SAMEORIGIN
CSL-Asset: PW102
Date: Sat, 23 Mar 2024 23:20:19 GMT
Content-Length: 17450
Strict-Transport-Security: max-age=157680000
Domain Information
Domain Nameserver Information
Host | IP Address | Country | |
---|---|---|---|
dbru.br.ns.els-gms.att.net | 68.94.156.134 | United States of America | |
dmtu.mt.ns.els-gms.att.net | 99.99.99.134 | United States of America |
Full WHOIS Lookup
cslbehring.co.uk
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 06-Sep-2017
Registrar:
Markmonitor Inc. [Tag = MARKMONITOR]
URL: https://www.markmonitor.com
Relevant dates:
Registered on: 09-Aug-2006
Expiry date: 09-Aug-2024
Last updated: 07-Jul-2022
Registration status:
Registered until expiry date.
Name servers:
dbru.br.ns.els-gms.att.net
dmtu.mt.ns.els-gms.att.net
WHOIS lookup made at 23:20:24 23-Mar-2024
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2024.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at https://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.